Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

2.
3.

Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Easthope SE, Perry CM.

Drugs Aging. 2002;19(3):231-48. Review.

PMID:
12027782
4.

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.

Holmstrom S, Buchholz P, Walt J, Wickstrøm J, Aagren M.

Curr Med Res Opin. 2005 Nov;21(11):1875-83. Review.

PMID:
16307709
5.

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.

Curr Med Res Opin. 2007 Mar;23(3):601-8. Review.

PMID:
17355741
6.

Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

Eisenberg DL, Toris CB, Camras CB.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S105-15. Review.

PMID:
12204706
7.

[Bimatoprost therapy in glaucoma].

Călugăru D, Călugăru M.

Oftalmologia. 2009;53(3):34-45. Review. Romanian.

PMID:
19899545
8.

Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension.

Orme M, Collins S, Dakin H, Kelly S, Loftus J.

Curr Med Res Opin. 2010 Mar;26(3):511-28. doi: 10.1185/03007990903498786. Review.

PMID:
20014995
9.

Efficacy and tolerability of latanoprost compared with timolol in the treatment of patients with chronic angle-closure glaucoma.

Lou H, Zong Y, Ge YR, Cheng JW, Wei RL.

Curr Med Res Opin. 2014 Jul;30(7):1367-73. doi: 10.1185/03007995.2014.905825. Epub 2014 Mar 27. Review.

PMID:
24641069
10.

Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.

Fung AT, Reid SE, Jones MP, Healey PR, McCluskey PJ, Craig JC.

Br J Ophthalmol. 2007 Jan;91(1):62-8. Epub 2006 Sep 6. Review.

11.

The intraocular pressure-lowering effect of prostaglandin analogs combined with topical β-blocker therapy: a systematic review and meta-analysis.

Webers CA, Beckers HJ, Zeegers MP, Nuijts RM, Hendrikse F, Schouten JS.

Ophthalmology. 2010 Nov;117(11):2067-74.e1-6. doi: 10.1016/j.ophtha.2010.03.024. Review.

PMID:
20619459
12.

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J.

Br J Ophthalmol. 2009 Mar;93(3):316-21. doi: 10.1136/bjo.2007.135111. Epub 2008 Nov 19. Review.

13.

Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.

Plosker GL, Keam SJ.

Pharmacoeconomics. 2006;24(3):297-314. Review.

PMID:
16519552
14.

[Monotherapy with lipid structural derivatives in glaucoma].

Călugăru D, Călugăru M.

Oftalmologia. 2010;54(2):30-43. Review. Romanian.

PMID:
20827909
15.
16.

Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management.

Cantor LB.

Expert Opin Investig Drugs. 2001 Apr;10(4):721-31. Review.

PMID:
11281821
17.

An update on bimatoprost in glaucoma therapy.

Cantor LB.

Expert Opin Pharmacother. 2002 Dec;3(12):1753-62. Review.

PMID:
12472372
18.

Efficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysis.

Lou H, Wang H, Zong Y, Cheng JW, Wei RL.

Curr Med Res Opin. 2015 Jun;31(6):1139-47. doi: 10.1185/03007995.2015.1039504. Review.

PMID:
25867658
19.

Effects of travoprost in the treatment of open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis.

Cheng JW, Xi GL, Wei RL, Cai JP, Li Y.

Curr Ther Res Clin Exp. 2009 Aug;70(4):335-50. doi: 10.1016/j.curtheres.2009.08.006. Review.

20.

Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Curran MP.

Drugs Aging. 2009;26(12):1049-71. doi: 10.2165/11203210-000000000-00000. Review.

PMID:
19929032

Supplemental Content

Support Center